TWIST1 and colorectal carcinoma: Furthermore, researchers have observed that in oxaliplatin-resistant CRC cells, Twist1 is stabilized by HK II via a ubiquitination degradation mechanism, thus exacerbating the progression of EMT and conferring resistance to oxaliplatin [90].